These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32053760)

  • 41. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis.
    Ishikawa H; Akedo I; Umesaki Y; Tanaka R; Imaoka A; Otani T
    J Am Coll Nutr; 2003 Feb; 22(1):56-63. PubMed ID: 12569115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
    Ludwig WD; Teichmann JV; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
    Klin Padiatr; 1990; 202(4):243-52. PubMed ID: 2203938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute myelogenous leukaemia in children under 2 years--experiences of the West German AML studies BFM-78, -83 and -87. AML-BFM Study Group.
    Vormoor J; Ritter J; Creutzig U; Boos J; Heyen P; Ludwig WD; Harbott J; Löffler H; Schellong G
    Br J Cancer Suppl; 1992 Aug; 18():S63-7. PubMed ID: 1503929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [First experience with the modified program NHL-BFM-90 application in adult patients with primary diffuse large B-cell gastric lymphosarcoma with unfavourable prognosis].
    Zvonkov EE; Krasil'nikova BB; Makhinia VA; Kaplanskaia IB; Kravchenko SK; Karagiulian SR; Grzhimolovskiĭ AV; Kuznetsov AN; Magomedova AU; Shukhman IM; Bariakh EA; Giliazitdinova EA; Gubkin AV; Lorie IuIu; Kremenetskaia AM; Vorob'ev AI
    Ter Arkh; 2006; 78(7):38-46. PubMed ID: 16944749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
    Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
    J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87. AML-BFM-Group.
    Ritter J; Creutzig U; Schellong G
    Leukemia; 1992; 6 Suppl 2():59-62. PubMed ID: 1578943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience.
    Reiter A
    Baillieres Clin Haematol; 1994 Jun; 7(2):321-37. PubMed ID: 7803904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Incidence and prognostic significance of Auer rods in children with acute myeloid leukemia in the studies AML-BFM-78 and -83].
    Vormoor J; Ritter J; Creutzig U; Schellong G
    Klin Padiatr; 1989; 201(4):227-32. PubMed ID: 2674529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
    Nachman J; Sather HN; Gaynon PS; Lukens JN; Wolff L; Trigg ME
    J Clin Oncol; 1997 Jun; 15(6):2222-30. PubMed ID: 9196134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Improved results in the treatment of acute myeloid leukemia - Results of study AML-BFM-93 in East Germany with comparisons to the preceding studies AML-I-82 and AML-II-87].
    Steinbach D; Dörffel W; Eggers G; Holfeld E; Kluba U; Krause I; Lauterbach I; Reiss T; Rieske K; Scharfe V; Schumacher R; Weigel H; Weinmann G; Zintl F; Hermann J
    Klin Padiatr; 2001; 213(4):162-8. PubMed ID: 11528549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
    Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H
    J Clin Oncol; 2001 May; 19(10):2705-13. PubMed ID: 11352963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.
    Schrappe M; Reiter A; Zimmermann M; Harbott J; Ludwig WD; Henze G; Gadner H; Odenwald E; Riehm H
    Leukemia; 2000 Dec; 14(12):2205-22. PubMed ID: 11187912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of acute lymphoblastic leukemia in childhood and adolescence: results of the multicenter therapy study ALL-BFM 81].
    Schrappe M; Beck J; Brandeis WE; Feickert HJ; Gadner H; Graf N; Havers W; Henze G; Jobke A; Kornhuber B
    Klin Padiatr; 1987; 199(3):133-50. PubMed ID: 3306128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toxicity, supportive care and costs of two chemotherapy protocols for treatment of childhood ALL in Russia: BFM 90m and MB 91.
    von Stackelberg A; Karatchunsky A; Kudrjashova J; Miakova N; Belikova L; Rumiantzev A; Hartmann R; Henze G
    Eur J Cancer; 1999 Sep; 35(9):1349-55. PubMed ID: 10658526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
    Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A bivariate whole-genome linkage scan suggests several shared genomic regions for obesity and osteoporosis.
    Tang ZH; Xiao P; Lei SF; Deng FY; Zhao LJ; Deng HY; Tan LJ; Shen H; Xiong DH; Recker RR; Deng HW
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2751-7. PubMed ID: 17473065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical characteristics and treatment results of pediatric B-cell non-Hodgkin lymphoma patients in a single center.
    Karadeniz C; Oguz A; Citak EC; Uluoglu O; Okur V; Demirci S; Okur A; Aksakal N
    Pediatr Hematol Oncol; 2007 Sep; 24(6):417-30. PubMed ID: 17710659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparing estimates of body fat in children using published bioelectrical impedance analysis equations.
    Williams J; Wake M; Campbell M
    Int J Pediatr Obes; 2007; 2(3):174-9. PubMed ID: 17999283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.